Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)

NCT02397057 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT02397057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02397057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2015
Completion date
January 31, 2018
Enrollment
209 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome (rls)